Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
about
Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status.Development of a copper-clioquinol formulation suitable for intravenous use.Hydroxycobalamin catalyzes the oxidation of diethyldithiocarbamate and increases its cytotoxicity independently of copper ions
P2860
Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Development and optimization o ...... e, an active anticancer agent.
@en
Development and optimization o ...... e, an active anticancer agent.
@nl
type
label
Development and optimization o ...... e, an active anticancer agent.
@en
Development and optimization o ...... e, an active anticancer agent.
@nl
prefLabel
Development and optimization o ...... e, an active anticancer agent.
@en
Development and optimization o ...... e, an active anticancer agent.
@nl
P2093
P2860
P50
P356
P1476
Development and optimization o ...... te, an active anticancer agent
@en
P2093
Léon Sanche
Malathi Anantha
Wieslawa H Dragowska
P2860
P304
P356
10.2147/IJN.S137347
P407
P577
2017-05-31T00:00:00Z